Publisher Correction: Oncolytic viruses as engineering platforms for combination immunotherapy
- PMID: 29728690
- DOI: 10.1038/s41568-018-0019-2
Publisher Correction: Oncolytic viruses as engineering platforms for combination immunotherapy
Abstract
In the online html version of this article, the affiliations for Jessica L. Pettigrew and John C. Bell were not correct. Jessica L. Pettigrew is at the Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada and John C. Bell is at the Center for Innovative Cancer Therapeutics, Ottawa Hospital Research Institute, Ottawa, Ontario, Canada. This is correct in the print and PDF versions of the article and has been corrected in the html version.
Erratum for
-
Oncolytic viruses as engineering platforms for combination immunotherapy.Nat Rev Cancer. 2018 Jul;18(7):419-432. doi: 10.1038/s41568-018-0009-4. Nat Rev Cancer. 2018. PMID: 29695749 Review.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources